These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 28901276)

  • 1. Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development.
    Samoylova TI; Braden TD; Spencer JA; Bartol FF
    Curr Med Chem; 2017 Nov; 24(35):3907-3920. PubMed ID: 28901276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infective and inactivated filamentous phage as carriers for immunogenic peptides.
    Samoylova TI; Norris MD; Samoylov AM; Cochran AM; Wolfe KG; Petrenko VA; Cox NR
    J Virol Methods; 2012 Jul; 183(1):63-8. PubMed ID: 22575687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of phage-GnRH chemical conjugates for potential use in cat and dog immunocontraception.
    Samoylov A; Cox N; Cochran A; Wolfe K; Donovan C; Kutzler M; Petrenko V; Baker H; Samoylova T
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():406-11. PubMed ID: 23279551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.
    Hassapis KA; Stylianou DC; Kostrikis LG
    Viruses; 2014 Dec; 6(12):5047-76. PubMed ID: 25525909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a filamentous phage display peptide library.
    Fagerlund A; Myrset AH; Kulseth MA
    Methods Mol Biol; 2014; 1088():19-33. PubMed ID: 24146394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine.
    Hashemi H; Bamdad T; Jamali A; Pouyanfard S; Mohammadi MG
    J Virol Methods; 2010 Feb; 163(2):440-4. PubMed ID: 19903497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of inovirus-associated vector vaccines using phage-display technologies.
    Stern Z; Stylianou DC; Kostrikis LG
    Expert Rev Vaccines; 2019 Sep; 18(9):913-920. PubMed ID: 31373843
    [No Abstract]   [Full Text] [Related]  

  • 8. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.
    van Houten NE; Zwick MB; Menendez A; Scott JK
    Vaccine; 2006 May; 24(19):4188-200. PubMed ID: 16488517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filamentous bacteriophage: A prospective platform for targeting drugs in phage-mediated cancer therapy.
    Garg P
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S1-S10. PubMed ID: 30900613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of human posterior head 20 (hPH20) and homo sapiens sperm acrosome associated 1 (hSPACA1) immunocontraceptive epitopes and their effects on fertility in male and female mice.
    Chen X; Liu X; Ren X; Li X; Wang L; Zang W
    Reprod Fertil Dev; 2016 Mar; 28(4):416-27. PubMed ID: 25209425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive vaccines for wildlife: a review.
    Kirkpatrick JF; Lyda RO; Frank KM
    Am J Reprod Immunol; 2011 Jul; 66(1):40-50. PubMed ID: 21501279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccines in immunocontraception.
    Ferro VA; Mordini E
    Curr Opin Mol Ther; 2004 Feb; 6(1):83-9. PubMed ID: 15011785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
    Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
    Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocontraception for Animals: Current Status and Future Perspective.
    Naz RK; Saver AE
    Am J Reprod Immunol; 2016 Apr; 75(4):426-39. PubMed ID: 26412331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
    Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
    Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.
    van Houten NE; Henry KA; Smith GP; Scott JK
    Vaccine; 2010 Mar; 28(10):2174-2185. PubMed ID: 20056188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of a 9-mer phage display pVIII-library with regulated peptide density.
    Fagerlund A; Myrset AH; Kulseth MA
    Appl Microbiol Biotechnol; 2008 Oct; 80(5):925-36. PubMed ID: 18716770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.
    O'Rourke JP; Peabody DS; Chackerian B
    Curr Opin Virol; 2015 Apr; 11():76-82. PubMed ID: 25829254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filamentous bacteriophage fd as an antigen delivery system in vaccination.
    Prisco A; De Berardinis P
    Int J Mol Sci; 2012; 13(4):5179-5194. PubMed ID: 22606037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Display of HIV-1 Envelope Protein on Lambda Phage Scaffold as a Vaccine Platform.
    Mattiacio JL; Brewer M; Dewhurst S
    Methods Mol Biol; 2017; 1581():245-253. PubMed ID: 28374253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.